Sort
10,766 grants matching “checkpoint inhibitor”
Brain Tumor Clinical and Clinical Research Program (Clinical Support Services)
$1,948,127Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
Molecularly Targeted Radiosensitization of Locally Advanced Cancers
$1,946,064Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2024 · CA
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
$1,943,851Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Overcoming the Tumor Microenvironment
$1,936,000Wendell A Lim · University Of California, San Francisco · U54 · FY2019 · CA
Clinical and Mechanistic Investigations of Salivary Gland Dysfunction
$1,927,479Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$1,925,677Peter Karl Sorger · Harvard Medical School · U54 · FY2022 · CA
MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC
$1,924,560Cara L Haymaker · University Of Tx Md Anderson Can Ctr · U24 · FY2025 · CA
MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC
$1,924,560Ignacio I. Wistuba · University Of Tx Md Anderson Can Ctr · U24 · FY2023 · CA
Project 3
$1,921,470Jinming Gao · Ut Southwestern Medical Center · U54 · FY2019 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,918,695Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment
$1,916,095George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA
Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment
$1,916,095George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2025 · CA
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$1,907,385Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,905,452E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2018 · CA
Analysis of high dimensional genomic dataset to reveal mechanistic insights on divergent outcomes of head and neck cancer using system biology modeling coupled with experimental validation
$1,899,042Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DE
In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response
$1,898,361Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2021 · CA
Investigating and Targeting Replication Stress in Small Cell Lung Cancer
$1,893,978Tony Tung Huang · New York University School Of Medicine · P01 · FY2025 · CA
Investigating and Targeting Replication Stress in Small Cell Lung Cancer
$1,893,978Tony Tung Huang · New York University School Of Medicine · P01 · FY2024 · CA
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
$1,890,317Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2017 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,884,842Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
SPORE in Myeloid Malignancies
$1,881,692Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2020 · CA
SPORE in Prostate Cancer
$1,881,134Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2025 · CA
Mechanisms of Nucleic Acid Enzymes - Pol Beta and Mammalian Base Repair Enzymes
$1,880,631Samuel H Wilson · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
Project 1: Enabling innate-adaptive immune crosstalk by improving NK cell trafficking and resistance to suppression
$1,879,957Dean A Lee · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA
Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment
$1,877,772George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA